ArticleJournal of the National Comprehensive Cancer Network : JNCCN2017

Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer.

Huei-Ting Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.